Orphalan announces data from secondary analyses of the CHELATE trial for maintenance patients with Wilson's Disease - Data from the company's CHELATE trial to be presented today during an oral presentation
Investegate announcements from Orphalan, Orphalan announces data from secondary analyses of the CHELATE trial for maintenance patients with Wilson’s Disease